Synergistic activity of JAK2 and BCL-2 inhibition against B-cell acute lymphoblastic leukemia

被引：0

作者：

Rinella, Sean ^{[1
]}

Hess, Nicholas ^{[1
]}

Bell, Haley ^{[1
]}

Shi, Lei ^{[1
]}

Rui, Lixin ^{[1
]}

Capitini, Christian ^{[1
]}

机构：

[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e22002

引用

页数：1

共 50 条

[31] Genetic or pharmacological inactivation of CREBBP sensitizes B-cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition
Gimenez, Alicia Garcia
Ditcham, Jonathan
Azazi, Dhoyazan M.
Meduri, Eshwar
Asby, Ryan
Sakakini, Nathalie
Lopez, Cecile K.
Narayan, Nisha
Bagri, Jaana
Beinortas, Tumas
Singh, Shuchi Agrawal
Giotopoulos, George
Murphy, Michael P.
Horton, Sarah J.
Huntly, Brian J.
Richardson, Simon E.
CANCER RESEARCH, 2024, 84 (06)
[32] Intrinsic and synergistic activity of ABT-199 in B-cell precursor acute lymphoblastic leukemia
Seyfried, F.
Demir, S.
Hoerl, R.
Zinngrebe, J.
Scheffold, A.
Koehrer, S.
Stilgenbauer, S.
Debatin, K-M
Meyer, L. H.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 200 - 200
[33] CRLF2 and JAK2 in B-Progenitor Acute Lymphoblastic Leukemia: A Novel Association in Oncogenesis
Roll, J. Devon
Reuther, Gary W.
CANCER RESEARCH, 2010, 70 (19) : 7347 - 7352
[34] Transcriptome-Based Molecular Subtypes Improve the Classification of B Cell Acute Lymphoblastic Leukemia with JAK2 Translocation
Huang, Bingqing
Jia, Yujiao
Wang, Haoxu
Wang, Huijun
Sun, Qi
Li, Chengwen
Wei, Hui
Mi, Yingchang
Zhu, Xiaofan
Wang, Jianxiang
Xiao, Zhijian
BLOOD, 2024, 144 : 2842 - 2842
[35] Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor
Chen Shumin
Li Ye
Wang Zheng
Feng Lin
Jia Yueping
Mo Xiaodong
Wang Yu
Jiang Qian
Huang Xiaojun
Lai Yueyun
中华医学杂志英文版, 2023, 136 (11)
[36] Targeting BCL-2 in B-cell lymphomas
Davids, Matthew S.
BLOOD, 2017, 130 (09) : 1081 - 1088
[37] Improved outcomes in E2A::HLF positive B-cell acute lymphoblastic leukemia by chimeric antigen receptor T cell therapy and BCL-2 inhibitor
Chen, Shumin
Li, Ye
Wang, Zheng
Feng, Lin
Jia, Yueping
Mo, Xiaodong
Wang, Yu
Jiang, Qian
Huang, Xiaojun
Lai, Yueyun
CHINESE MEDICAL JOURNAL, 2023, 136 (11) : 1382 - 1384
[38] BCL-2 MAINTAINS B-CELL MEMORY
NUNEZ, G
HOCKENBERY, D
MCDONNELL, TJ
SORENSEN, CM
KORSMEYER, SJ
NATURE, 1991, 353 (6339) : 71 - 73
[39] Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Forero-Castro, Maribel
Robledo, Cristina
Benito, Rocio
Bodega-Mayor, Irene
Rapado, Inmaculada
Hernandez-Sanchez, Maria
Abaigar, Maria
Maria Hernandez-Sanchez, Jesus
Quijada-Alamo, Miguel
Maria Sanchez-Pina, Jose
Sala-Valdes, Monica
Araujo-Silva, Fernanda
Kohlmann, Alexander
Luis Fuster, Jose
Arefi, Maryam
de las Heras, Natalia
Riesco, Susana
Rodriguez, Juan N.
Hermosin, Lourdes
Ribera, Jordi
Camos Guijosa, Mireia
Ramirez, Manuel
de Heredia Rubio, Cristina Diaz
Barragan, Eva
Martinez, Joaquin
Ribera, Jose M.
Fernandez-Ruiz, Elena
Hernandez-Rivas, Jesus-Maria
BRITISH JOURNAL OF CANCER, 2017, 117 (02) : 256 - 265
[40] Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Maribel Forero-Castro
Cristina Robledo
Rocío Benito
Irene Bodega-Mayor
Inmaculada Rapado
María Hernández-Sánchez
María Abáigar
Jesús Maria Hernández-Sánchez
Miguel Quijada-Álamo
José María Sánchez-Pina
Mónica Sala-Valdés
Fernanda Araujo-Silva
Alexander Kohlmann
José Luis Fuster
Maryam Arefi
Natalia de las Heras
Susana Riesco
Juan N Rodríguez
Lourdes Hermosín
Jordi Ribera
Mireia Camos Guijosa
Manuel Ramírez
Cristina Díaz de Heredia Rubio
Eva Barragán
Joaquín Martínez
José M Ribera
Elena Fernández-Ruiz
Jesús-María Hernández-Rivas
British Journal of Cancer, 2017, 117 : 256 - 265

← 1 2 3 4 5 →